Researcher.Life Logo

Molecular Pain : Impact Factor & More

eISSN: 1744-8069pISSN: 1744-8069
JournalOpen Access

Aims and Scope of Molecular Pain

Molecular Pain is a peer-reviewed open access medical journal covering all aspects of research on pain. It was established in 2005 and is published by BioMed Central. The editors-in-chief are Jianguo Gu (University of Alabama at Birmingham) and Min Zhuo (University of Toronto), who was also the founding editor of the journal. It is sponsored by the University of Cincinnati College of Medicine. Less

Key Metrics

CiteScore
5.6
Impact Factor
< 5
SJR
Q3Molecular Medicine
SNIP
0.85
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Molecular Pain

Molecular Pain Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SAGE PUBLICATIONS INC
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2500
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Molecular Pain ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Molecular Pain

EXPRESS: Effects of cooling on the excitability of trigeminal Aβ-afferent nociceptors in mice: involvement of temperature-sensitive K2P channels.
  • 19 Jun 2026
  • Molecular pain
EXPRESS: Assessing Pain Sensitivity with COX-2 Biomarkers: A Novel Approach in Healthy Volunteers.
  • 5 Jun 2026
  • Molecular pain
Dezocine alleviates cancer-induced bone pain and suppresses intraosseous tumor growth in renal cell carcinoma via the NAMPT/NAD+ axis
  • 5 Jun 2026
  • Molecular Pain
EXPRESS: Precursor signaling redefined: proneurotrophin-3, not neurotrophin-3, in primary sensory neurons as an instigator in neuropathic pain.
  • 5 Jun 2026
  • Molecular pain
EXPRESS: Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu's subcutaneous needling in neuropathic pain treatment.
  • 3 Jun 2026
  • Molecular pain
EXPRESS: RIN1 inhibited TRPV1-dependent pain sensitization in a mouse model of bone cancer pain.
  • 26 May 2026
  • Molecular pain
EXPRESS: Effects of cooling on the excitability of trigeminal Aβ-afferent nociceptors in mice: involvement of temperature-sensitive K2P channels.
  • 19 Jun 2026
  • Molecular pain
EXPRESS: Assessing Pain Sensitivity with COX-2 Biomarkers: A Novel Approach in Healthy Volunteers.
  • 5 Jun 2026
  • Molecular pain
Dezocine alleviates cancer-induced bone pain and suppresses intraosseous tumor growth in renal cell carcinoma via the NAMPT/NAD+ axis
  • 5 Jun 2026
  • Molecular Pain
EXPRESS: Precursor signaling redefined: proneurotrophin-3, not neurotrophin-3, in primary sensory neurons as an instigator in neuropathic pain.
  • 5 Jun 2026
  • Molecular pain
EXPRESS: Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu's subcutaneous needling in neuropathic pain treatment.
  • 3 Jun 2026
  • Molecular pain
EXPRESS: RIN1 inhibited TRPV1-dependent pain sensitization in a mouse model of bone cancer pain.
  • 26 May 2026
  • Molecular pain

FAQs on Molecular Pain